Inogen Inc — Director's Dealing 2021

Aug 11, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2021-08-09

Reporting Person: Glezer Stanislav (EVP, Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-09	Restricted Stock Unit	$	A	12298	Acquired		Common Stock (12298)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

F2: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on September 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.